Sign up for our FREE Pain E-Weekly for more coverage like this sent to your inbox!
The development team will use peptides from spider venom, which can block pain, to create drugs. According to Bloomberg Businessweek, the project team will include University of Queensland researchers Paul Alewood and Glenn King.
Related Articles on Pain Management:
5 Business Practices of Boston PainCare: a Case Study of a Successful Pain Management Practice
Florida Pain Regulations Might Hurt Care for Some Patients in Pain
Scripps Research Institute Scientists Identify Protein that Sends Pain Signals
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.